MDwise is delivering a new subsidized plan with a consumer-directed look to low-income adults in Indiana
State Medicaid programs face a number of pressing issues over the next two years, include policy changes, growing demand, and, of course, financing. Experts agree that even with federal matching funds states cannot realistically cover all their uninsured residents, nor can they guarantee affordable coverage. A large-scale solution is necessary, but reforms will take years to develop.
The Healthy Indiana Plan (HIP), which began enrolling beneficiaries in January 2008, is the first state model that has a consumer-driven look to it. It includes a high-deductible health plan and health savings account offered to low-income adults who wouldn't otherwise qualify for Medicaid. HIP is generating interest because:
"There was an unforeseen, significant demand for Healthy Indiana," says Charlotte MacBeth, president of MDwise, which covers more than 10,000 HIP members. "A lot of states have medically needy categories, but Indiana has never adopted a medically needy program. There was a population of adults who needed medical care who were probably the first ones to sign up. The state also did an excellent job promoting the program, so that contributed to the initial growth. But it's my understanding the growth hasn't slowed down. It's continuing to exceed expectations."
New Population
Pent-up demand for HIP is staggering. State officials predict the program will eventually enroll a total of 120,000 adults earning less than 200% of the federal poverty level. Any low-income adult without access to an employer plan who has been uninsured for six months is eligible.
Based on documented demand, it's almost certain HIP will reach the cap in the first quarter of 2009. At that point, eligible applicants will be turned away.
AI Benefits PBMs, Health Plans and Formulary Decision Making | AMCP Nexus 2024
October 21st 2024Health plans and PBMs are using AI to aggregate data, summarize information and enhance their formulary decision-making processes, according to Douglas S. Burgoyne, Pharm.D., MBA, FAMCP, adjunct associate professor at the University of Utah College of Pharmacy.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
The Link between GLP-1 Drugs and Diabetic Retinopathy Is Not So Clear | AAO 2024
Published: October 21st 2024 | Updated: October 21st 2024Clinical and other trials for GLP-1 therapies have found an association between these drugs and diabetic retinopathy complications in patients. But this could be an early worsening of disease unrelated to treatment.
Read More
In our latest "Meet the Board" podcast episode, Managed Healthcare Executive Editors caught up with editorial advisory board member, Eric Hunter, CEO of CareOregon, to discuss a number of topics, one including the merger that never closed with SCAN Health Plan due to local opposition from Oregonians.
Listen